Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 109,893 | 541,271 | 426,256 | 237,160 | 103,673 |
| Depreciation Amortization | 3,692 | 14,848 | 11,304 | 7,783 | 3,913 |
| Income taxes - deferred | -20,282 | -11,976 | N/A | -16,930 | 3,329 |
| Accounts receivable | -31,608 | -19,895 | -75,017 | -29,659 | 16,292 |
| Accounts payable and accrued liabilities | N/A | -679 | N/A | N/A | N/A |
| Other Working Capital | -44,218 | -137,163 | -97,017 | -65,452 | -39,214 |
| Other Operating Activity | 38,488 | 8,722 | -25,815 | -3,578 | -19,726 |
| Operating Cash Flow | $55,965 | $395,128 | $239,711 | $129,324 | $68,267 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 90,834 | -220,038 | -8,714 | -108,418 | -92,140 |
| PPE Investments | -9,184 | -18,972 | -13,111 | -6,730 | -2,393 |
| Purchase Of Investment | -143,503 | -80,587 | -200,676 | -5,000 | -20,000 |
| Purchase Sale Intangibles | -11 | -134 | -134 | -123 | -15 |
| Other Investing Activity | -11 | 34,866 | 34,866 | -123 | -15 |
| Investing Cash Flow | $-61,864 | $-284,731 | $-187,635 | $-120,271 | $-114,548 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -5,888 | -5,888 | -449 | -223 |
| Common Stock Repurchased | -132,489 | -9,450 | N/A | N/A | N/A |
| Financing Cash Flow | $-132,489 | $-15,338 | $-5,888 | $-449 | $-223 |
| Exchange Rate Effect | 363 | 57 | -4,615 | -2,550 | 3,861 |
| Beginning Cash Position | 576,757 | 481,641 | 481,641 | 481,641 | 481,641 |
| End Cash Position | 438,732 | 576,757 | 523,214 | 487,695 | 438,998 |
| Net Cash Flow | $-138,025 | $95,116 | $41,573 | $6,054 | $-42,643 |
| Free Cash Flow | |||||
| Operating Cash Flow | 55,965 | 395,128 | 239,711 | 129,324 | 68,267 |
| Capital Expenditure | -9,184 | -18,972 | -13,111 | -6,730 | -2,393 |
| Free Cash Flow | 46,781 | 376,156 | 226,600 | 122,594 | 65,874 |